The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 7331 -7341
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0803917

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Wells, A. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wells, A. D.

New Insights into the Molecular Basis of T Cell Anergy: Anergy Factors, Avoidance Sensors, and Epigenetic Imprinting

Andrew D. Wells1

Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine and The Children’s Hospital of Philadelphia, Philadelphia, PA 19104

The vertebrate immune system has evolved to deal with invasive pathogens, but this adaptation comes at the expense of immunopathology. Among a number of mechanisms that coevolved to control adaptive immunity is anergy, the functional inactivation of T lymphocytes that respond to Ag in the absence of inflammation. In this review, I highlight a series of intracellular proteins in quiescent T cells that function to integrate signals from Ag, costimulatory, and growth factor receptors. These factors ensure that cells that fail to engage all three pathways are shunted into an alternative transcriptional program designed to dissuade them from participating in subsequent immune responses. Recent studies indicate that anergy is the combined result of factors that negatively regulate proximal TCR-coupled signal transduction, together with a program of active transcriptional silencing that is reinforced through epigenetic mechanisms.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Address correspondence and reprint requests to Dr. Andrew D. Wells, University of Pennsylvania, Children’s Hospital of Philadelphia, 916E Abramson Research Center, 3615 Civic Center Boulevard, Philadelphia, PA 19104. E-mail address: adwells{at}mail.med.upenn.edu

2 Abbreviations used in this paper: Treg, regulatory T cell; ARRE, Ag receptor response element; CD28RE, CD28 response element; CDK, cyclin-dependent kinase; CREM, cAMP response element modulator; DGK, diacylglycerol kinase; GRAIL, gene related to anergy in lymphocytes; HAT, histone acetyltransferase; HDAC, histone deacetylase; IKK, I{kappa}B kinase; PLC{gamma}, phospholipase C{gamma}; mTOR, mammalian target of rapamycin; PKC{theta}, protein kinase C{theta}; TRAF, TNFR-associated factor.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M.-C. St. Rose, H. Z. Qui, S. Bandyopadhyay, M. A. Mihalyo, A. T. Hagymasi, R. B. Clark, and A. J. Adler
The E3 Ubiquitin Ligase Cbl-b Regulates Expansion but Not Functional Activity of Self-Reactive CD4 T Cells
J. Immunol., October 15, 2009; 183(8): 4975 - 4983.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.